BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27992692)

  • 21. TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study.
    Raaschou P; Frisell T; Askling J;
    Ann Rheum Dis; 2015 Dec; 74(12):2137-43. PubMed ID: 25107559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study.
    Lim CH; Lin CH; Chen DY; Chen YM; Chao WC; Liao TL; Chen HH
    PLoS One; 2016; 11(11):e0166339. PubMed ID: 27832150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis.
    Baecklund E; Backlin C; Iliadou A; Granath F; Ekbom A; Amini RM; Feltelius N; Enblad G; Sundström C; Klareskog L; Askling J; Rosenquist R
    Arthritis Rheum; 2006 Dec; 54(12):3774-81. PubMed ID: 17133544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis.
    Holmqvist M; Gränsmark E; Mantel A; Alfredsson L; Jacobsson LT; Wallberg-Jonsson S; Askling J
    Ann Rheum Dis; 2013 Apr; 72(4):541-6. PubMed ID: 22610975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.
    Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LT; Kristensen LE; Feltelius N; Hetland ML; Askling J;
    Ann Rheum Dis; 2017 Jan; 76(1):105-111. PubMed ID: 27147709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks.
    Holmqvist M; Ljung L; Askling J
    Ann Rheum Dis; 2017 Oct; 76(10):1642-1647. PubMed ID: 28710095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis.
    Mikuls TR; Endo JO; Puumala SE; Aoun PA; Black NA; O'Dell JR; Stoner JA; Boilesen EC; Bast MA; Bergman DA; Ristow KM; Ooi M; Armitage JO; Habermann TM
    J Clin Oncol; 2006 Apr; 24(10):1597-602. PubMed ID: 16520462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas.
    Geborek P; Bladström A; Turesson C; Gulfe A; Petersson IF; Saxne T; Olsson H; Jacobsson LT
    Ann Rheum Dis; 2005 May; 64(5):699-703. PubMed ID: 15695534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.
    Holmqvist ME; Wedrén S; Jacobsson LT; Klareskog L; Nyberg F; Rantapää-Dahlqvist S; Alfredsson L; Askling J
    Arthritis Rheum; 2009 Oct; 60(10):2861-9. PubMed ID: 19790058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
    Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L
    Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: drug-specific comparisons in the Swedish Biologics Register.
    Simard JF; Neovius M; Askling J;
    Arthritis Rheum; 2012 Nov; 64(11):3502-10. PubMed ID: 22886739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis.
    Ljung L; Simard JF; Jacobsson L; Rantapää-Dahlqvist S; Askling J;
    Arthritis Rheum; 2012 Jan; 64(1):42-52. PubMed ID: 21898355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study.
    Askling J; Klareskog L; Blomqvist P; Fored M; Feltelius N
    Ann Rheum Dis; 2006 Sep; 65(9):1184-7. PubMed ID: 16414970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
    Wolfe F; Caplan L; Michaud K
    Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
    Eriksson JK; Johansson K; Askling J; Neovius M
    Ann Rheum Dis; 2015 Apr; 74(4):648-54. PubMed ID: 24323395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists.
    Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven RF; Klareskog L
    Ann Rheum Dis; 2007 Oct; 66(10):1339-44. PubMed ID: 17261532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.
    Wolfe F; Michaud K
    Arthritis Rheum; 2004 Jun; 50(6):1740-51. PubMed ID: 15188349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.
    Raaschou P; Simard JF; Holmqvist M; Askling J;
    BMJ; 2013 Apr; 346():f1939. PubMed ID: 23568792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a population-based cohort study.
    Shen TC; Lin CL; Chen CH; Tu CY; Hsia TC; Shih CM; Hsu WH; Sung FC
    QJM; 2014 Jul; 107(7):537-43. PubMed ID: 24497528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer.
    Ji J; Liu X; Sundquist K; Sundquist J
    Rheumatology (Oxford); 2011 Aug; 50(8):1513-8. PubMed ID: 21498553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.